Celon Pharma S.A. (CLN.WA)
Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products.
20.55-0.02%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-11.0%
The outlook
Celon Pharma S.A. currently reads as neutral based on hold — 3.4 avg of 5 analysts, mixed vs its moving averages, 38% of the way from its 52-week low to high, avg target -1% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusHold — 3.4 avg of 5 analysts
Price trendMixed vs its moving averages
52-week range38% of the way from its 52-week low to high
Price targetAvg target -1% vs current price
Analyst price target
~12-month · 5 analysts20.44average target-0.5% vs now
Now 20.55
Low 16.00High 25.50
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$799.6M
52-wk high
23.95
52-wk low
18.50
50-day avg
20.42
200-day avg
21.07
Trailing P/E
10.1